Medsinglong secures Series B+ financing exclusively led by Sunye Group

Medsinglong, China's leading one-stop service platform for medical device going global, has officially announced the completion of its Series B+ financing round, which was exclusively invested by Sunye Group.

Over the past 18 months, Medsinglong has completed three financing rounds. Its previous shareholders include the Yongfeng County Parent Fund managed by Gantou, Plum Ventures, and Chengwei Capital, fully demonstrating investors' strong recognition of the company's long-term strategy and execution capabilities.

Currently, the going global of Chinese medical devices is shifting from quantitative expansion to qualitative improvement. According to data from the China Chamber of Commerce for Import and Export of Medicines and Health Products, China's medical device export value reached USD 50.469 billion in 2025, representing a year-on-year increase of 3.54 percent. Against the industry backdrop of normalized volume-based procurement and intensifying domestic competition, an increasing number of medical device companies are turning their sights to overseas markets. The medical device going global space is entering a deep zone, where a simple cost-performance advantage is no longer sufficient, and localized deepening centered on service and efficiency is becoming the key to competition.

Founded in 2013, Medsinglong is an S2B e-commerce platform focused on cross-border going global of medical devices, striving to become the JD.com of Chinese medical device going global. After more than a decade of development, the company's business footprint has expanded to cover 204 countries and regions worldwide, providing one-stop smart medical solutions to over ten thousand medical institutions, and has maintained a compound annual growth rate of over 40 percent since its establishment.

This investment from Sunye Group further validates the long-term value of Medsinglong's business model. With the support of this round of funding, the company will accelerate the expansion of its overseas warehouse network and local team build-up, continuously solidifying its leading position in the S2B field of medical device going global.